Alkermes
ALKS
#3093
Rank
ยฃ3.65 B
Marketcap
ยฃ22.16
Share price
0.75%
Change (1 day)
-9.35%
Change (1 year)

Alkermes (ALKS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ0.44 Billion

According to Alkermes's latest financial reports the company's total liabilities are ยฃ0.44 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Alkermes - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ0.47 B-35.77%
2023-12-31ยฃ0.73 B-3.67%
2022-12-31ยฃ0.76 B12.59%
2021-12-31ยฃ0.67 B4.31%
2020-12-31ยฃ0.64 B17.95%
2019-12-31ยฃ0.54 B6.61%
2018-12-31ยฃ0.51 B17.09%
2017-12-31ยฃ0.43 B4.98%
2016-12-31ยฃ0.41 B14.66%
2015-12-31ยฃ0.36 B8.93%
2014-12-31ยฃ0.33 B
2013-03-31ยฃ0.34 B-6.23%
2012-03-31ยฃ0.36 B864.37%
2011-03-31ยฃ37.68 M-44.04%
2010-03-31ยฃ67.34 M-26%
2009-03-31ยฃ91 M-47.92%
2008-03-31ยฃ0.17 B-6.09%
2007-03-31ยฃ0.18 B-27.57%
2006-03-31ยฃ0.25 B44.57%
2005-03-31ยฃ0.17 B69.94%
2004-03-31ยฃ0.10 B-36.79%
2003-03-31ยฃ0.16 B-5.96%
2002-03-31ยฃ0.17 B2.48%
2001-03-31ยฃ0.17 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Acorda Therapeutics
ACOR
ยฃ0.20 B-55.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ58.76 B 13,033.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ85.22 B 18,947.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ86.80 B 19,299.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ51.40 B 11,389.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ24.47 B 5,369.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Sanofi
SNY
ยฃ49.56 B 10,976.89%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
ยฃ46.94 B 10,391.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland